1 / 4

Nephrotic Syndrome Diagnostics & Therapeutics Market Trends, Size, Competitive A

The global nephrotic syndrome diagnostics & therapeutics market is anticipated to grow at a CAGR of 5.6% during the forecast period. Nephrotic syndrome is a kidney disease in which the body excretes an excessive amount of protein in the urine.

Meenoo
Download Presentation

Nephrotic Syndrome Diagnostics & Therapeutics Market Trends, Size, Competitive A

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Nephrotic Syndrome Diagnostics & Therapeutics Market, Size, Share, Analysis Report & Forecast to 2027 To Request a Sample of our Report on Nephrotic Syndrome Diagnostics & Therapeutics Market: https://www.omrglobal.com/request-sample/nephrotic-syndrome-diagnostics-therapeutics- market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global nephrotic syndrome diagnostics & therapeutics market global nephrotic syndrome diagnostics & therapeutics market is anticipated to grow at a CAGR of around 5.6% during the forecast period (2021-2027). The key factor to drive the market growth includesthe increasing prevalence of diabetes that results in increased chances of nephrotic syndrome. For instance, In the European Union, approximately 32.3 million adults were diagnosed with diabetes in 2019, up from an estimated 16.8 million adults in 2000. In 2019, it was estimated that around 24.2 million people in Europe will be having diabetes but will go undiagnosed.Since 2000, the number of men diagnosed with diabetes has more than doubled, rising from about 7.3 million in 2000 to 16.7 million in 2019. Women with diabetes have also increased significantly, from 9.5 million in 2000 to 15.6 million in 2019. (Get 15% Discount on Buying this Report) A full Report of Nephrotic Syndrome Diagnostics & Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/nephrotic-syndrome-diagnostics-therapeutics- market Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in April 2019, Angion announced a partnership agreement with Nephrotic Syndrome Study Network (NEPTUNE)in order to investigate ANG-3070. This clinical research is based on understanding and treatment of kidney disorders.These findings of the research will supportdetermining the inclusion requirements for a biomarker stratified prospective clinical trial evaluating the safety and efficacy of ANG-3070 in primary Focal segmental glomerulosclerosis (FSGS) patients, ensuring that the most likely patients benefit from treatment. To Request a Sample of our Report on Nephrotic Syndrome Diagnostics & Therapeutics Market: https://www.omrglobal.com/request-sample/nephrotic-syndrome-diagnostics-therapeutics- market Market Coverage •The market number available for – 2020-2027 •Base year- 2020 •Forecast period- 2021-2027 Segment Covered- •By Diagnosis Test •By Treatment Regions Covered- •North America •Europe •Asia-Pacific •Rest of the World •Competitive Landscape- Global Nephrotic Syndrome Diagnostics & Therapeutics Market Report Segment By Diagnosis Tests •Urinalysis •Blood Tests •Kidney Biopsy •Others (CT Scan, Renal Ultra-Sonography)

  3. By Treatment •Blood Pressure Lowering Medications •Angiotensin-Converting Enzyme (ACE) Inhibitors •Angiotensin Receptor Blockers (ARBs) •Others (Renin Inhibitors and Benazepril) •Immune System-Suppressing Medications •Cholesterol-Reducing Medications •Others (Blood Thinners) Regional Analysis North America •United States •Canada Europe •UK •Germany •Spain •France •Italy •Rest of Europe Asia-Pacific •India •China •Japan •Rest oF APAC Rest of The World •Latin America •Middle East & Africa Company Profiles •Abbott Laboratories •Asahi Kasei Pharma Corp. •AstraZeneca PLC •Aurinia Pharmaceuticals Inc. •Bristol-Myers Squibb Co. •DaVita Inc. •Eli Lilly and Co. •GeneDx Inc. •GlaxoSmithKline PLC •Johnson and Johnson Services Inc.

  4. •Mallinckrodt LLC •Novartis International AG •Pfizer Inc. •Sanofi SA •ZyVersa Therapeutics, Inc. Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/nephrotic-syndrome-diagnostics-therapeutics-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related